GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labomar SpA (MIL:LBM) » Definitions » FCF Margin %

Labomar SpA (MIL:LBM) FCF Margin % : 12.58% (As of Dec. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Labomar SpA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Labomar SpA's Free Cash Flow for the six months ended in Dec. 2022 was €6.29 Mil. Labomar SpA's Revenue for the six months ended in Dec. 2022 was €50.02 Mil. Therefore, Labomar SpA's FCF Margin % for the quarter that ended in Dec. 2022 was 12.58%.

As of today, Labomar SpA's current FCF Yield % is 0.00%.

The historical rank and industry rank for Labomar SpA's FCF Margin % or its related term are showing as below:

MIL:LBM' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3.9
Current: 3.9


During the past 6 years, the highest FCF Margin % of Labomar SpA was 3.90%. The lowest was 0.00%. And the median was 0.00%.

MIL:LBM's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.49 vs MIL:LBM: 3.90


Labomar SpA FCF Margin % Historical Data

The historical data trend for Labomar SpA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labomar SpA FCF Margin % Chart

Labomar SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Margin %
Get a 7-Day Free Trial 15.50 14.27 2.80 8.27 3.90

Labomar SpA Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.25 2.59 13.25 -6.48 12.58

Competitive Comparison of Labomar SpA's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Labomar SpA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labomar SpA's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labomar SpA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Labomar SpA's FCF Margin % falls into.



Labomar SpA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Labomar SpA's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=3.583/91.824
=3.90 %

Labomar SpA's FCF Margin for the quarter that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=6.291/50.021
=12.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labomar SpA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Labomar SpA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Labomar SpA (MIL:LBM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Via Nazario Sauro, 35/l, Istrana, ITA, 31036
Labomar SpA is engaged in the business of developing food supplements, nutraceuticals, probiotics, medical devices, cosmetics, and food for special medical purposes. The products of the company are developed to support and protect the immune system, oral hygiene, bone health, and skincare.

Labomar SpA (MIL:LBM) Headlines

No Headlines